Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Chest|November 13, 1999
Assessment of health-related quality of life in patients with interstitial lung diseaseJ A Chang, J R Curtis, D L Patrick, et al.
Nephron|January 1, 1989
Acute metabolic alkalosis during haemodialysisD Sethi, J R Curtis, D L Topham, et al.
Clinical Nephrology|February 1, 1976
Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal and renal failureJ R Curtis, G C Goode, J Herrington, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 10, 2001
Primary care residency graduates' reported training needsD E DeWitt, L S Robins, J R Curtis, et al.
The American Journal of Psychiatry|July 1, 1991
Relationships between requests for psychiatric consultations and psychiatric diagnoses in long-term-care facilitiesJ P Loebel, S Borson, T Hyde, et al.
Intensive Care Medicine|April 24, 2015
Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic reviewN M Mark, S G Rayner, N J Lee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparinE Anastassiades, H Ireland, A Flynn, et al.
Haemostasis|January 1, 1986
On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failureD A Lane, A Flynn, H Ireland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 7, 2017
Impact of neighbourhood-level inequity on paediatric diabetes careA B M Clarke, D Daneman, J R Curtis, et al.
Archives of Internal Medicine|June 10, 2000
Why don't patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care cliniciansJ R Curtis, D L Patrick, E S Caldwell, et al.
Pageof 19